The global vaginal rejuvenation market size was valued at USD 1.8 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 13.2% from 2023 to 2030. Changing women’s lifestyles and growing awareness of associated therapies or surgeries are expected to drive the market during the forecast period. In addition, growing awareness of cosmetic procedures, especially female aesthetic genital surgery, is anticipated to fuel market growth in the future. The outbreak of COVID-19 led many aesthetic facilities to completely halt their services and permanently cancel appointments, as they were considered non-essential and high-contact in nature. Surgical aesthetic treatments such as vaginal rejuvenation also witnessed a setback and the number of procedures declined due to the pandemic.
The increasing popularity of radiofrequency-based treatments is also driving the market. Radiofrequency-based devices such as Viveve and Geneveve are gaining popularity owing to their non-invasive and safe single-session result nature respectively. Viveve delivers volumetric radiofrequency of (90J/cm²) 3-5mm in vaginal tissue, which improves blood circulation, whereas the 30-minute session by Geneveve treatment has improved the health and quality of lives of thousands of women worldwide. Moreover, the treatment has proven to be effective for dryness due to childbirth and loss of vaginal elasticity.
Urinary incontinence, pelvic organ prolapse, overactive bladder syndrome, and fecal incontinence are some of the disorders prevalent in the U.S. Approximately 24% of women are suffering from one of the following conditions in the country. Precisely, 16% of women are suffering from urinary incontinence, 9% of women are affected by fecal incontinence, and 3% of women with pelvic organ prolapse. This number is anticipated to rise from 28.1 million (2010) to 43.8 million (2050). Thus, rising cases of uterine prolapse, birthing injuries, and urinary incontinence in women due to growing life expectancy are expected to drive the market.
A surging demand for energy-based treatments is also anticipated to fuel the market in the forthcoming years. Energy-based devices for targeted surgery use either thermal or non-thermal energy for different layers of the vaginal tissue. This stimulates the regeneration of collagen, toughens the elastic fibers, helps neovascularization, and recovers vaginal lubrication. According to an Indian study, demand for esthetic vaginal procedures increased from 3.9% in 2012 to 28.97% in 2015.
Moreover, the growing success rate of radiofrequency and laser technologies in improving tissue properties, dermatology, and aesthetic medicine is affecting the growth of the market. The application of these technologies in vaginal rejuvenation has significantly expanded therapeutic indications in various biological tissue-related issues. Hence, devices incorporated with these technologies help women relish, reclaim, and improve their femininity in an optimal manner.
The pandemic affected the global aesthetic industry, especially invasive cosmetic surgeries, as governments in many countries mandated temporary shutdowns of aesthetic facilities. The third and fourth quarters of 2020 witnessed a gradual easing of lockdown conditions, with many plastic surgeons and aesthetic centers resuming taking in appointments and consultations, but with strict guidelines and limited patients per day.
The number of labiaplasty procedures carried out globally decreased by 13% in 2020 as compared to 2019, according to the International Society of Aesthetic Plastic Surgery. However, the market is expected to recover from the effects of the pandemic, as the American Society of Plastic Surgeons stated that there is pent-up patient demand for invasive as well as non-invasive treatments to be addressed in the post-pandemic period.
The cosmetic vaginal rejuvenation segment held the largest market share of around 60.0% in 2022 owing to the increasing demand for surgeries, such as labiaplasty. Labiaplasty is a commonly performed surgery due to an increasing number of issues related to the genital area. By treatment type, the vaginal rejuvenation market is divided into reconstructive vaginal rejuvenation and cosmetic vaginal rejuvenation.
Reconstructive vaginal rejuvenation is further sub-segmented as perineoplasty and vaginoplasty. The reconstructive vaginal rejuvenation segment is anticipated to grow lucratively during the forecast period owing to the steadily increasing number of patients reporting progression in prolapse, decreased vaginal sensation regarding vaginal wall laxity, and sexual dysfunction. Reconstructive vaginal rejuvenation is focused on repairing and correcting the structure of the vagina, especially after C-section delivery. This helps women to continue their lifestyle without complications or pain during urination, intercourse, and menstruation.
North America registered a market share of 21.3% in 2022, owing to the increasing number of vaginal procedures and the high disposable income of consumers. According to the American Society of Plastic Surgeons (ASPS) 2020, labiaplasty costs approximately USD 4000. The demand for labiaplasty surgery grew by more than 24% in 2019. Moreover, the surgery offers 90% satisfaction among its patients. Owing to this factor, vaginal rejuvenation surgery is anticipated to be one of the common trends in the coming years.
The growing number of surgeons in the region, the increasing spending power of consumers, and the growing number of research activities in the domain are a few other factors driving market growth in North America. In addition, the increasing adoption of modern technologies and rising efforts for the promotion of these techniques are predicted to affect the growth of the regional market for vaginal rejuvenation.
Latin America is expected to hold a considerable share of the market in the next seven years owing to the increasing awareness of vaginal laxity treatment in the region, especially in rapidly developing economies such as Brazil and Mexico, and the growing popularity of various types of vaginal surgeries among patients. Moreover, the growing popularity of medical tourism in emerging countries is expected to drive the regional market.
Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The European market for vaginal rejuvenation is expected to grow at a significant rate owing to the well-developed healthcare infrastructure and growing awareness of women’s sexual health in the region. Additionally, a progressive attitude towards addressing intimate health concerns and cultural openness in Europe contribute to market growth.
Key players are adopting growth strategies, such as mergers and acquisitions, new product launches, developments in existing strategies, expansion of product portfolios, and more to drive revenue in the market. In June 2022, Sinclair announced the launch of the V-VR handpiece to complete its women’s health portfolio. V-VR is a clinically proven solution for vaginal rejuvenation. In December 2020, Viveve Medical Inc. obtained the U.S. FDA 510 (K) clearance for expanding the production capacity for its treatment tips used with Viveve’s Cryogen-cooled Monopolar Radiofrequency (CMRF) technology.
vConfidence is one of the leading players in the industry that offers modernized RF and laser technologies to cure women’s vaginal health. In 2017, they announced the addition of 20 offices in North Carolina to provide effective and safe treatment. In recent years, they have launched devices such as Intima, FemiLift, Viveve Geneveve, and FemTouch. When combined with other treatment protocols, these devices offer consistent and non-invasive results. Post a single treatment session spanning 5 minutes, patients can resume their daily activities immediately. The treatment helps tighten the vaginal tunnel, improve menopausal dryness, balance pH, and improve thinning vaginal walls.
In October 2017, Venus Concept launched Venus Fiore for internal vaginal health restoration, labia tightening, and mons pubis reduction in India. Some prominent key players in the global vaginal rejuvenation market include:
Alma Lasers
Lutronic
ThermiGen, LLC
vConfidence
BTL Group of Companies
Venus Concept
Fotona
Almirall
Hologic
Report Attribute |
Details |
Market size value in 2023 |
USD 1.97 billion |
Revenue forecast in 2030 |
USD 4.71 billion |
Growth rate |
CAGR of 13.2% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Report updated |
September 2023 |
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Treatment type, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE; Kuwait |
Key companies profiled |
Almirall; Alma Lasers; Lutronic; Fotona; ThermiGen, LLC; vConfidence; BTL Group of Companies; Venus Concept; Hologic |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global vaginal rejuvenation market report based on treatment type and region:
Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
Reconstructive Vaginal Rejuvenation
Perineoplasty
Vaginoplasty
Cosmetic Vaginal Rejuvenation
G-Spot amplification
Labioplasty
Hymenoplasty
Hoodectomy
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global vaginal rejuvenation market size was estimated at USD 1.8 billion in 2022 and is expected to reach USD 1.97 billion in 2023.
b. The global vaginal rejuvenation market is expected to grow at a compound annual growth rate of 13.2% from 2023 to 2030 to reach USD 4.71 billion by 2030.
b. The cosmetic vaginal rejuvenation segment dominated the vaginal rejuvenation market with a share of 63.5% in 2022. This is attributable to the growing demand for vaginal surgeries, especially in developed countries.
b. Some key players operating in the vaginal rejuvenation market include Alma Lasers, Lutronic, ThermiGen, LLC, Viveve, BTL Group of Companies, VenusConcept, Fotona, Almirall, and Hologic
b. Key factors that are driving the vaginal rejuvenation market growth include changing lifestyles along with rising disposable income and knowledge about the availability of various treatment options.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With COVID-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for COVID-19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.